CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma MicroenvironmentTomohiro Fujiwara, John H. Healey, Andrew Chandler et al.|Molecular Cancer Therapeutics|2021Cited by 258